Aarti Drugs (India) Price Prediction
| AARTIDRUGS | 460.80 2.40 0.52% |
Oversold Vs Overbought
24
Oversold | Overbought |
Quarterly Earnings Growth (0.11) | Wall Street Target Price 555 | EPS Estimate Current Quarter 32.25 | Quarterly Revenue Growth (0.07) |
Using Aarti Drugs hype-based prediction, you can estimate the value of Aarti Drugs Limited from the perspective of Aarti Drugs response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Aarti Drugs to buy its stock at a price that has no basis in reality. In that case, they are not buying Aarti because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Aarti Drugs after-hype prediction price | INR 462.69 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Aarti |
Aarti Drugs After-Hype Price Prediction Density Analysis
As far as predicting the price of Aarti Drugs at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Aarti Drugs or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Aarti Drugs, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Aarti Drugs Estimiated After-Hype Price Volatility
In the context of predicting Aarti Drugs' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Aarti Drugs' historical news coverage. Aarti Drugs' after-hype downside and upside margins for the prediction period are 414.72 and 463.68, respectively. We have considered Aarti Drugs' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Aarti Drugs is very steady at this time. Analysis and calculation of next after-hype price of Aarti Drugs Limited is based on 3 months time horizon.
Aarti Drugs Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Aarti Drugs is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Aarti Drugs backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Aarti Drugs, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.36 | 0.99 | 1.89 | 217.44 | 2 Events / Month | 1 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
460.80 | 462.69 | 0.41 |
|
Aarti Drugs Hype Timeline
Aarti Drugs Limited is presently traded for 460.80on National Stock Exchange of India of India. The entity has historical hype elasticity of 1.89, and average elasticity to hype of competition of -217.44. Aarti is anticipated to increase in value after the next headline, with the price projected to jump to 462.69 or above. The average volatility of media hype impact on the company the price is about 18.86%. The price gain on the next news is projected to be 0.41%, whereas the daily expected return is presently at -0.36%. The volatility of related hype on Aarti Drugs is about 0.16%, with the expected price after the next announcement by competition of 243.36. The company reported the revenue of 25.09 B. Net Income was 1.71 B with profit before overhead, payroll, taxes, and interest of 8.06 B. Assuming the 90 days trading horizon the next anticipated press release will be in a few days. Check out Aarti Drugs Basic Forecasting Models to cross-verify your projections.Aarti Drugs Related Hype Analysis
Having access to credible news sources related to Aarti Drugs' direct competition is more important than ever and may enhance your ability to predict Aarti Drugs' future price movements. Getting to know how Aarti Drugs' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Aarti Drugs may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| MRF | MRF Limited | (2,583) | 3 per month | 0.00 | (0.25) | 1.57 | (1.78) | 4.82 | |
| BOSCHLTD | Bosch Limited | 242.95 | 3 per month | 1.74 | (0) | 2.72 | (2.91) | 8.80 | |
| BAJAJHLDNG | Bajaj Holdings Investment | (75.94) | 4 per month | 1.35 | (0.02) | 3.24 | (2.09) | 8.34 | |
| VHL | Vardhman Holdings Limited | 0.00 | 2 per month | 3.26 | 0.04 | 9.72 | (5.06) | 33.81 |
Aarti Drugs Additional Predictive Modules
Most predictive techniques to examine Aarti price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Aarti using various technical indicators. When you analyze Aarti charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Aarti Drugs Predictive Indicators
The successful prediction of Aarti Drugs stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Aarti Drugs Limited, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Aarti Drugs based on analysis of Aarti Drugs hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Aarti Drugs's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Aarti Drugs's related companies.
Story Coverage note for Aarti Drugs
The number of cover stories for Aarti Drugs depends on current market conditions and Aarti Drugs' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Aarti Drugs is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Aarti Drugs' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Aarti Drugs Short Properties
Aarti Drugs' future price predictability will typically decrease when Aarti Drugs' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Aarti Drugs Limited often depends not only on the future outlook of the potential Aarti Drugs' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Aarti Drugs' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 91.9 M | |
| Cash And Short Term Investments | 89.3 M |
Additional Tools for Aarti Stock Analysis
When running Aarti Drugs' price analysis, check to measure Aarti Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aarti Drugs is operating at the current time. Most of Aarti Drugs' value examination focuses on studying past and present price action to predict the probability of Aarti Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aarti Drugs' price. Additionally, you may evaluate how the addition of Aarti Drugs to your portfolios can decrease your overall portfolio volatility.